DEERFIELD MANAGEMENT COMPANY, L.P. Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$2.2T
Holdings
90
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (90 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —GW PHARMACEUTICALS PLC | 1,008,475 | $133.9B | 6.23% | |
| 2 | —PORTOLA PHARMACEUTICALS INC | 5,639,727 | $128.1B | 5.96% | |
| 3 | —HORIZON PHARMA PLC | 6,434,439 | $116.7B | 5.43% | |
| 4 | —NXSTAGE MEDICAL INC | 4,099,175 | $102.4B | 4.76% | |
| 5 | —AVEXIS INC | 2,236,701 | $92.2B | 4.29% | |
| 6 | —HORIZON PHARMA INVT LTD | 82,600,000 | $80.1B | 3.73% | |
| 7 | —HEALTHWAYS INC | 54,382,000 | $79.2B | 3.68% | |
| 8 | —ADEPTUS HEALTH INC | 1,600,861 | $68.9B | 3.21% | |
| 9 | —DBV TECHNOLOGIES S A | 1,743,229 | $63.3B | 2.95% | |
| 10 | VNDAVANDA PHARMACEUTICALS INC | 3,435,576 | $57.2B | 2.66% | |
| 11 | NVROEURNEVRO CORP | 536,355 | $56.0B | 2.60% | |
| 12 | —MYLAN N V | 1,423,334 | $54.3B | 2.52% | |
| 13 | XNCRXENCOR INC | 2,210,900 | $54.1B | 2.52% | |
| 14 | —ARRAY BIOPHARMA INC | 45,000,000 | $53.3B | 2.48% | |
| 15 | AERIEURAERIE PHARMACEUTICALS INC | 1,338,829 | $50.5B | 2.35% | |
| 16 | —FLAMEL TECHNOLOGIES SA | 4,072,809 | $50.5B | 2.35% | |
| 17 | TRIB 4 04/01/45TRINITY BIOTECH INVT LTD | 48,000,000 | $46.8B | 2.18% | |
| 18 | —WRIGHT MED GROUP INC | 40,050,000 | $42.8B | 1.99% | |
| 19 | —AETNA INC NEW | 366,000 | $42.3B | 1.97% | |
| 20 | —ENDOLOGIX INC | 40,941,000 | $39.2B | 1.82% | |
| 21 | —AAC HLDGS INC | 2,189,849 | $38.1B | 1.77% | |
| 22 | —UNIVERSAL AMERN CORP NEW | 4,592,060 | $35.1B | 1.63% | |
| 23 | —NIVALIS THERAPEUTICS INC | 3,732,412 | $30.3B | 1.41% | |
| 24 | EHTHEHEALTH INC | 2,640,609 | $29.6B | 1.38% | |
| 25 | WBAWALGREENS BOOTS ALLIANCE INC | 355,957 | $28.7B | 1.33% | |
| 26 | HUMHUMANA INC | 159,500 | $28.2B | 1.31% | |
| 27 | GLPGGALAPAGOS NV | 423,112 | $27.4B | 1.27% | |
| 28 | —SYROS PHARMACEUTICALS INC | 1,812,778 | $25.1B | 1.17% | |
| 29 | —AUDENTES THERAPEUTICS INC | 1,403,653 | $25.0B | 1.16% | |
| 30 | —TESARO INC | 242,300 | $24.3B | 1.13% | |
| 31 | DVADAVITA INC | 350,000 | $23.1B | 1.08% | |
| 32 | EDITEDITAS MEDICINE INC | 1,709,400 | $23.0B | 1.07% | |
| 33 | —SPARK THERAPEUTICS INC | 368,000 | $22.1B | 1.03% | |
| 34 | BCRXBIOCRYST PHARMACEUTICALS | 4,401,846 | $19.4B | 0.90% | |
| 35 | GKOSGLAUKOS CORP | 503,277 | $19.0B | 0.88% | |
| 36 | SEMSELECT MED HLDGS CORP | 1,354,662 | $18.3B | 0.85% | |
| 37 | —INVUITY INC | 1,282,598 | $17.6B | 0.82% | |
| 38 | AXGNAXOGEN INC | 1,893,030 | $17.1B | 0.80% | |
| 39 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 27,715,000 | $17.0B | 0.79% | |
| 40 | —FIVE PRIME THERAPEUTICS INC | 311,000 | $16.3B | 0.76% | |
| 41 | —BLUEBIRD BIO INC | 224,000 | $15.2B | 0.71% | |
| 42 | CTMXCYTOMX THERAPEUTICS INC | 943,433 | $14.8B | 0.69% | |
| 43 | —PROTEON THERAPEUTICS INC | 1,570,467 | $14.7B | 0.68% | |
| 44 | —FOAMIX PHARMACEUTICALS LTD | 1,307,058 | $12.1B | 0.56% | |
| 45 | ARRYEURARRAY BIOPHARMA INC | 1,650,000 | $11.1B | 0.52% | |
| 46 | —AKARI THERAPEUTICS PLC | 1,150,700 | $9.8B | 0.46% | |
| 47 | —ALIMERA SCIENCES INC | 5,878,015 | $8.8B | 0.41% | |
| 48 | —MYOKARDIA INC | 499,800 | $8.2B | 0.38% | |
| 49 | ARDXARDELYX INC | 618,643 | $8.0B | 0.37% | |
| 50 | —ARALEZ PHARMACEUTICALS INC | 1,644,583 | $8.0B | 0.37% | |
| 51 | —ST JUDE MED INC | 100,000 | $8.0B | 0.37% | |
| 52 | —AXOVANT SCIENCES LTD | 568,005 | $8.0B | 0.37% | |
| 53 | EXASEXACT SCIENCES CORP | 357,680 | $6.6B | 0.31% | |
| 54 | —LOXO ONCOLOGY INC | 251,000 | $6.6B | 0.31% | |
| 55 | 2L9BLUEPRINT MEDICINES CORP | 215,586 | $6.4B | 0.30% | |
| 56 | —STEADYMED LTD | 1,756,370 | $6.3B | 0.29% | |
| 57 | —OXFORD IMMUNOTEC GLOBAL PLC | 464,541 | $5.8B | 0.27% | |
| 58 | —ESSA PHARMA INC | 2,121,601 | $5.8B | 0.27% | |
| 59 | —BIOSCRIP INC | 1,971,228 | $5.7B | 0.26% | |
| 60 | —CAS MED SYS INC | 3,200,000 | $5.5B | 0.26% | |
| 61 | —KEMPHARM INC | 1,084,443 | $4.9B | 0.23% | |
| 62 | NSTGEURNANOSTRING TECHNOLOGIES INC | 226,691 | $4.5B | 0.21% | |
| 63 | —PSIVIDA CORP | 1,492,824 | $4.5B | 0.21% | |
| 64 | —CATABASIS PHARMACEUTICALS IN | 683,375 | $4.2B | 0.20% | |
| 65 | SCYXEURSCYNEXIS INC | 1,048,000 | $4.1B | 0.19% | |
| 66 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 171,428 | $4.0B | 0.18% | |
| 67 | —MOLINA HEALTHCARE INC | 3,000,000 | $3.6B | 0.17% | |
| 68 | —GENOCEA BIOSCIENCES INC | 687,257 | $3.5B | 0.16% | |
| 69 | —ACORDA THERAPEUTICS INC | 161,552 | $3.4B | 0.16% | |
| 70 | EX9EXELIXIS INC | 246,907 | $3.2B | 0.15% | |
| 71 | INFIQINFINITY PHARMACEUTICALS INC | 1,935,942 | $3.0B | 0.14% | |
| 72 | ACRSACLARIS THERAPEUTICS INC | 116,000 | $3.0B | 0.14% | |
| 73 | —PROTEOSTASIS THERAPEUTICS IN | 186,000 | $2.9B | 0.13% | |
| 74 | —EPIZYME INC | 291,179 | $2.9B | 0.13% | |
| 75 | VYGRVOYAGER THERAPEUTICS INC | 235,294 | $2.8B | 0.13% | |
| 76 | TREURTRILLIUM THERAPEUTICS INC | 172,307 | $2.5B | 0.12% | |
| 77 | —PRONAI THERAPEUTICS INC | 1,387,115 | $2.5B | 0.12% | |
| 78 | —RITE AID CORP | 275,000 | $2.1B | 0.10% | |
| 79 | —HEALTHWAYS INC | 76,000 | $2.0B | 0.09% | |
| 80 | —AGILE THERAPEUTICS INC | 250,000 | $1.7B | 0.08% | |
| 81 | ACURACURA PHARMACEUTICALS INC | 1,025,641 | $1.6B | 0.08% | |
| 82 | —OCERA THERAPEUTICS INC | 572,893 | $1.5B | 0.07% | |
| 83 | —NEOS THERAPEUTICS INC | 229,166 | $1.5B | 0.07% | |
| 84 | —THRESHOLD PHARMACEUTICAL INC | 2,202,160 | $1.5B | 0.07% | |
| 85 | TEVATEVA PHARMACEUTICAL INDS LTD | 30,000 | $1.4B | 0.06% | |
| 86 | REGNREGENERON PHARMACEUTICALS | 3,300 | $1.3B | 0.06% | |
| 87 | —PARATEK PHARMACEUTICALS INC | 100,000 | $1.3B | 0.06% | |
| 88 | BMRNBIOMARIN PHARMACEUTICAL INC | 13,800 | $1.3B | 0.06% | |
| 89 | —STREAMLINE HEALTH SOLUTIONS | 662,971 | $1.2B | 0.06% | |
| 90 | CLVSEURCLOVIS ONCOLOGY INC | 8,000 | $288.0M | 0.01% |